Taking Action on Excess Visceral Fat

Buckley, Rita
October 2012
MD Conference Express;Oct2012, p8
Academic Journal
The article discusses comments made by Professor Luc Van Gaal of the Antwerp University Hospital, Antwerp, Belgium on the challenges and options for dealing with abdominal obesity-related conditions. It notes that conventional antidiabetes therapies have often resulted to increased weight in patients with type 2 diabetes. Professor Van Gaal stresses that key actions such as assessing risk, initiating interventions to reduce total and visceral fat, and institute preventive measures should be made to address weight gain.


Related Articles

  • Visceral Adiposity Related to Cardiometabolic Risk and Type 2 Diabetes. Buckley, Rita // MD Conference Express;Oct2012, p6 

    The article discusses a computed-tomography imaging study which aims to determine the relationship of visceral adiposity to type 2 diabetes and cardiometabolic risk. It notes that 4277 patients, of whom 52% are males, were involved in the multinational study. It notes that patients were...

  • Stay slim--and sharp. McVEIGH, GLORIA // Prevention;Jul2006, Vol. 58 Issue 7, p76 

    This article reports on British research which links healthy weight maintenance and mental astuteness. The study found that inductive reasoning dropped in people with Type 2 diabetes, a common outcome of obesity. The author asserts that the brain works best within a narrow blood sugar range...

  • Neck Circumference as an Anthropometric Measure of Obesity in Diabetics. Aswathappa, Jagadamba; Garg, Sumit; Kutty, Karthiyanee; Shankar, Vinutha // North American Journal of Medical Sciences;Jan2013, Vol. 5 Issue 1, p28 

    Background: Obesity is a risk factor for type 2 diabetes mellitus. Insulin resistance is associated with visceral subcutaneous fat content. Neck circumference (NC) is a marker of upper body subcutaneous adipose tissue distribution. Aim: The aim of this study is to compare NC in diabetics and...

  • Role of the Endocannabinoid System in Abdominal Obesity and the Implications for Cardiovascular Risk. Rosenson, Robert S. // Cardiology;2009, Vol. 114 Issue 3, p212 

    Several cardiometabolic factors present in obese and insulin-resistant individuals represent a continuum of increasing risk for the development of type 2 diabetes and cardiovascular disease. The importance of abdominal obesity as an independent risk factor is underscored by its association with...

  • Weight Considerations in Pharmacotherapy for Type 2 Diabetes. Cheng, Vicky; Kashyap, Sangeeta R. // Journal of Obesity;2011, Vol. 2011, Special section p1 

    Obesity has been increasing in prevalence worldwide and the majority of patients with type 2 diabetes are either overweight or obese. Diabetes management in this population has been difficult since a number of antidiabetes agents are associated with weight gain. The effects of various...

  • Body Adiposity and Type 2 Diabetes: Increased Risk With a High Body Fat Percentage Even Having a Normal BMI. Gómez-Ambrosi, Javier; Silva, Camilo; Galofré, Juan C.; Escalada, Javier; Santos, Silvia; Gil, María J.; Valentí, Victor; Rotellar, Fernando; Ramírez, Beatriz; Salvador, Javier; Frühbeck, Gema // Obesity (19307381);Jul2011, Vol. 19 Issue 7, p1439 

    Obesity is the major risk factor for the development of prediabetes and type 2 diabetes. BMI is widely used as a surrogate measure of obesity, but underestimates the prevalence of obesity, defined as an excess of body fat. We assessed the presence of impaired glucose tolerance or impaired...

  • Agouti Expression in Human Adipose Tissue. Smith, Steven R.; Gawronska-Kozak, Barbara; Janderová, Lenka; Nguyen, Taylor; Murrell, Angela; Stephens, Jacqueline M.; Mynatt, Randall L. // Diabetes;Dec2003, Vol. 52 Issue 12, p2914 

    It is well recognized that the agouti/melanocortin system is an important regulator of body weight homeostasis. Given that agouti is expressed in human adipose tissue and that the ectopic expression of agouti in adipose tissue results in moderately obese mice, the link between agouti expression...

  • Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians. de Courten, Barbora Vozarova; Hanson, Robert L.; Funahashi, Tohru; Lindsay, Robert S.; Matsuzawa, Yuji; Tanaka, Sachiyo; Thameem, Farook; Gruber, Jonathan D.; Froguel, Philippe; Wolford, Johanna K. // Diabetes;Jan2005, Vol. 54 Issue 1, p284 

    Adiponectin is an abundant adipose tissue-derived protein with important metabolic effects. Plasma adiponectin levels are decreased in obese individuals, and low adiponectin levels predict insulin resistance and type 2 diabetes. Two variants in the adiponectin gene ACDC have been previously...

  • Progressive Reduction in Body Weight with Pramlintide Therapy in Obese Subjects with Type 2 Diabetes Treated with Diet and Exercise and/or Metformin. Edelman, Steve; Lush, Cameron; Kesty, Nicole; Burns, Colleen; Weyer, Christian; Frias, Juan // Diabetes;Jun2007 Supplement 1, Vol. 56, pA461 

    Pramlintide (PRAM), an analog of the β-cell hormone amylin, has several clinical effects relevant to obesity, including meal-related satiation, reduced food intake, and weight loss. We previously reported that 16-wk PRAM treatment resulted in a placebo (PBO)-corrected change in body weight...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics